May 2020 Issue Table Of Contents

From The Editor

• How We Arrived At A Series Of Unprecedented Events

Feature Articles

• BioEclipse Therapeutics — More Than Just A Story Of Rebranding
• Former Biopharma CEO Develops Novel Solution For The “Valley Of Death”

Capitol Perspectives

• $2 Trillion CARES Act Attempts  To Keep Health System Afloat

CEO Corner

• Becoming The CEO

From Principles and Policy to Execution

• When Leaders Fumble, Responsible Public Prepares To Ward Off A Pandemic

Companies To Watch

• Companies To Watch: argenx

Industry Research

• Technology In Clinical Trials: Differences By Company Size

Inside The Industry

• 5 Biopharma Execs Reveal Corporate Culture Best Practices
• A European Model For Innovative Bio Funding
• Working With The U.S Army To Achieve Tech Transfer Success
• Dealmakers In Life Sciences: More Active, More Creative
• Trade Secrets Or Patents?

Leadership Lessons

• How to Create a Lasting Culture:  Every Interaction Matters

Ask The Board

• What Has Been The Most Fulfilling Experience You’ve Had Regarding Mentoring?
• With The Growing Number Of Clinical Disappointments In Alzheimer’s Disease, How Will We Meet The Cognitive And Neurodegenerative Needs Of An Aging World Population?
• What Current Industry/Patient-Centricity Trends Are Encouraging Patient Participation In Clinical Trials?